These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 37736988)

  • 41. Update on treatment advances in combined-modality therapy for anal and rectal carcinomas.
    Meyer J; Balch G; Willett C; Czito B
    Curr Oncol Rep; 2011 Jun; 13(3):177-85. PubMed ID: 21465120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the primary staging of rectal cancer.
    Ozis SE; Soydal C; Akyol C; Can N; Kucuk ON; Yagcı C; Erkek AB; Kuzu MA
    World J Surg Oncol; 2014 Feb; 12():26. PubMed ID: 24484935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diagnostic accuracy of 3.0T high-resolution MRI for assessment mesorectal lymph node metastases in patients with rectal cancer].
    Chen Y; Yang X; Lu B; Xiao X; Zhuang X; Yu S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jul; 21(7):786-792. PubMed ID: 30051447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metastatic rectal adenocarcinoma and anal squamous cell carcinoma masquerading as vulvar lymphangioma circumscriptum.
    Soh JM; Scott GA; Pavlovitz BT; Mercurio MG
    J Obstet Gynaecol; 2016 Oct; 36(7):876-878. PubMed ID: 27616148
    [No Abstract]   [Full Text] [Related]  

  • 45. F-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography Has High Diagnostic Value for Pelvic and Distant Staging in Patients with High-risk Penile Carcinoma.
    Ottenhof SR; Djajadiningrat RS; Versleijen MWJ; Donswijk ML; van der Noort V; Brouwer OR; Graafland NM; Vegt E; Horenblas S
    Eur Urol Focus; 2022 Jan; 8(1):98-104. PubMed ID: 33685842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anal Squamous Cell Carcinoma: Radiation Therapy Alone Must Be Avoided.
    Almaazmi H; Taylor JP; Stem M; Yu D; Lo BD; Safar B; Efron JE
    J Surg Res; 2020 Mar; 247():530-540. PubMed ID: 31648811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the Literature.
    Abrams-Pompe RS; Fanti S; Schoots IG; Moore CM; Turkbey B; Vickers AJ; Walz J; Steuber T; Eastham JA
    Eur Urol Oncol; 2021 Jun; 4(3):370-395. PubMed ID: 33272865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic performance of
    Hotta M; Minamimoto R; Yano H; Gohda Y; Shuno Y
    Cancer Imaging; 2018 Jan; 18(1):4. PubMed ID: 29378659
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic impact of tumour burden assessed by metabolic tumour volume on FDG PET/CT in anal canal cancer.
    Gauthé M; Richard-Molard M; Fayard J; Alberini JL; Cacheux W; Lièvre A
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):63-70. PubMed ID: 27503193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical relevance of positron emission tomography/computed tomography-positive inguinal nodes in rectal cancer after neoadjuvant chemoradiation.
    Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Ono CR; Lynn P; Bailão Aguilar P; Nahas SC; Gama-Rodrigues J; Buchpiguel CA
    Colorectal Dis; 2013 Jun; 15(6):674-82. PubMed ID: 23374979
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary squamous cell carcinoma of the rectum: An update and implications for treatment.
    Guerra GR; Kong CH; Warrier SK; Lynch AC; Heriot AG; Ngan SY
    World J Gastrointest Surg; 2016 Mar; 8(3):252-65. PubMed ID: 27022453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metastatic incidence of (PET)CT positive lung hilar and retroperitoneal lymph nodes in esophageal cancer patients.
    Schurink B; Mazza E; Ruurda JP; Roeling TAP; Bleys RLAW; van Hillegersberg R
    Surg Oncol; 2020 Jun; 33():170-176. PubMed ID: 32561084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relative Value of Restaging MRI, CT, and FDG-PET Scan After Preoperative Chemoradiation for Rectal Cancer.
    Schneider DA; Akhurst TJ; Ngan SY; Warrier SK; Michael M; Lynch AC; Te Marvelde L; Heriot AG
    Dis Colon Rectum; 2016 Mar; 59(3):179-86. PubMed ID: 26855391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Can MR imaging be useful in differentiating low rectal cancer from anal cancer?
    Cattapan K; Chulroek T; Wancharoenrung D; Kordbacheh H; Harisinghani M
    Abdom Radiol (NY); 2019 Feb; 44(2):438-445. PubMed ID: 30171293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.
    Cooper KL; Meng Y; Harnan S; Ward SE; Fitzgerald P; Papaioannou D; Wyld L; Ingram C; Wilkinson ID; Lorenz E
    Health Technol Assess; 2011 Jan; 15(4):iii-iv, 1-134. PubMed ID: 21276372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of 18-fluorodeoxyglucose positron emission tomography-computed tomography on the staging and management of primary rectal cancer.
    Davey K; Heriot AG; Mackay J; Drummond E; Hogg A; Ngan S; Milner AD; Hicks RJ
    Dis Colon Rectum; 2008 Jul; 51(7):997-1003. PubMed ID: 18461399
    [TBL] [Abstract][Full Text] [Related]  

  • 57. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What Is the Utility of Restaging Imaging for Patients With Clinical Stage II/III Rectal Cancer After Completion of Neoadjuvant Chemoradiation and Prior to Proctectomy?
    Hendrick LE; Buckner JD; Guerrero WM; Shibata D; Hinkle NM; Monroe JJ; Glazer ES; Deneve JL; Dickson PV
    Am Surg; 2021 Feb; 87(2):242-247. PubMed ID: 32927959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of refractory metastatic anal squamous cell carcinoma following disease progression on traditional chemoradiation therapy.
    Silva NN; Eng C
    J Adv Pract Oncol; 2012 May; 3(3):161-9. PubMed ID: 25031942
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Positron emission tomography detection of distant metastatic or synchronous disease in patients with locally advanced rectal cancer receiving preoperative chemoradiation.
    Nahas CS; Akhurst T; Yeung H; Leibold T; Riedel E; Markowitz AJ; Minsky BD; Paty PB; Weiser MR; Temple LK; Wong WD; Larson SM; Guillem JG
    Ann Surg Oncol; 2008 Mar; 15(3):704-11. PubMed ID: 17882490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.